Urology, UT M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.
Bladder cancer remains one of the most deadly and most expensive diseases affecting modern society. The options currently available to patients with muscle invasive bladder cancer have remained essentially unchanged for the last generation. As the roles for surgery and chemotherapy in the management of this lethal disease have become better defined, so too have the limitations of these two treatment modalities. Despite the lack of groundbreaking clinical advances over the past two decades, the recent years have witnessed a notable increase in the amount of promising preclinical and early translational research that will greatly improve our understanding of the molecular underpinnings of bladder cancer. As this momentum in bladder cancer research continues to build, the next five to ten years show considerable potential for achieving the goal of bringing bladder cancer treatment into the age of personalized medicine.
Written by:
Shah JB, McConkey DJ, Dinney CP. Are you the author?
Reference: Clin Cancer Res. 2011 Mar 17. Epub ahead of print.
doi: 10.1158/1078-0432.CCR-10-2770
PubMed Abstract
PMID: 21415213
UroToday.com Bladder Cancer Section
